Skip to main content
Log in

An integrated approach to the pharmacokinetic analysis of drug absorption

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

An Erratum to this article was published on 01 August 1975

Abstract

A systematic approach to the estimation of bioavailability using both model-independent and pharmacokinetic techniques is introduced. The methods of Kwan-Till and Wagner-Nelson or Loo-Riegelman are integrated such that one is able to check many of the assumptions inherent in these techniques and make appropriate adjustments for apparent deviations. The proposed integrated method makes use of all available data (both plasma and urine) and leads to a better understanding of the absorption, distribution, metabolism, and excretion of the drug being studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

A(t) :

Cumulative amount of drug absorbed at timet

C p(t) :

Plasma concentration at timet

C T(t) :

Amount of drug in the tissue compartment divided by the volume of the central compartment

D :

Dose of drug administered

F :

Fraction of dose absorbed unmetabolized

f :

Fraction ofF · D excreted unchanged in the urine

U (t) :

Cumulative amount of drug excreted in the urine at timet

X T :

Amount of drug in the tissue compartment

δ :

Observed terminal slope for a one-compartment open model following nonintravascular drug administration

ɛ :

Observed slope on the residuals (estimate of the fast rate constant)

β :

Observed slow disposition rate constant for a two-compartment open model

k a :

First-order absorption rate constant

k e :

Elimination rate constant, one-compartment open model

k 13 :

Elimination rate constant, two-compartment open model

12, k21 :

Distribution rate constants, two-compartment open model

V d :

Apparent volume of distribution, one-compartment open model

V 1 :

Apparent volume of distribution of the central compartment for a two-compartment open model

Vcl,r :

Renal clearance of drug

Vcl,p :

Plasma clearance of drug

iv:

Drug administered intravenously

niv:

Drug administered by a nonvascular route

′:

Corrected on the basis of renal component of elimination alone

″:

Corrected on the basis of proportional changes in renal and nonrenal components of elimination

*:

Calculated by equation 22

W-N:

Wagner-Nelson

L-R:

Loo-Riegelman

K-T:

Kwan-Till

References

  1. J. G. Wagner and E. Nelson. Percent absorbed time plots derived from blood level and/or urinary excretion data.J. Pharm. Sci. 52:610–611 (1963).

    Article  CAS  PubMed  Google Scholar 

  2. J. C. K. Loo and S. Riegelman. New method for calculating the intrinsic absorption rate of drugs.J. Pharm. Sci. 57:918–928 (1968).

    Article  CAS  PubMed  Google Scholar 

  3. A. Rescigno and G. Segre.Drug and Tracer Kinetics, Blaisdell, Waltham, Mass., 1966, pp. 189–195.

    Google Scholar 

  4. L. Z. Benet and C.-W. N. Chiang. The use and application of deconvolution methods in pharmaceutics. InAbstracts of the 13th National Meeting of the APhA Academy of Pharmaceutical Sciences, Chicago, Vol. 2, Washington, D.C., 1972, pp. 169–171.

    Google Scholar 

  5. C. M. Metzler.A Users Manual for NONLIN, Technical Report 7292/69/7292/005, The Upjohn Company, Kalamazoo, Mich., November 25, 1969.

    Google Scholar 

  6. M. Berman and M. F. Weiss.Users Manual for SAAM, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Md., 1967.

    Google Scholar 

  7. K. C. Kwan and A. E. Till. Novel method for bioavailability assessment.J. Pharm. Sci. 62: 1494–1497 (1973).

    Article  CAS  PubMed  Google Scholar 

  8. J. G. Wagner and J. I. Northam. Estimation of volume of distribution and half-life of a compound after rapid intravenous injection.J. Pharm. Sci. 56:529–531 (1967).

    Article  CAS  PubMed  Google Scholar 

  9. S. Riegelman, J. C. K. Loo, and M. Rowland. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.J. Pharm. Sci. 57:117–123 (1968).

    Article  CAS  PubMed  Google Scholar 

  10. K. C. Kwan, D. A. Wadke, and E. L. Foltz. Pharmacokinetics of phosphonomycin in man. I. Intravenous administration.J. Pharm. Sci. 60:678–685 (1971).

    Article  CAS  PubMed  Google Scholar 

  11. L. Z. Benet. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.J. Pharm. Sci. 61:536–541 (1972).

    Article  CAS  PubMed  Google Scholar 

  12. Guidelines for Biopharmaceutical Studies in Man, APhA Academy of Pharmaceutical Sciences, Washington, D.C., 1972, pp. 13–14.

  13. J. C. K. Loo. Pharmacokinetic methods of assessing drug absorption: Evaluation and the application of kinetic methods in the investigation of bioavailability of solid oral dosage forms. Thesis, University of California, San Francisco, 1971, pp. 15–18.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/BF01066924.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Till, A.E., Benet, L.Z. & Kwan, K.C. An integrated approach to the pharmacokinetic analysis of drug absorption. Journal of Pharmacokinetics and Biopharmaceutics 2, 525–544 (1974). https://doi.org/10.1007/BF01070946

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01070946

Key words

Navigation